Synopsis

Source of validity: Scientific
Rating (out of 5): 2

There is emerging scientific interest in the use of probiotics for psoriasis, but the evidence is limited and preliminary. Psoriasis is an immune-mediated skin disorder, and recent research suggests that gut microbiota may influence immune function and inflammation. Several small clinical trials and animal studies have investigated the effect of oral probiotics on psoriasis severity. For example, a randomized controlled trial published in 2013 found that a mixture of probiotic strains (including Bifidobacterium and Lactobacillus) was associated with modest improvements in psoriasis symptoms compared to placebo. Some studies have documented changes in the gut microbiome in individuals with psoriasis, suggesting a potential therapeutic target. However, most studies are limited by small sample sizes, short durations, and inconsistent probiotic formulations.

Systematic reviews conclude that while there is a biological rationale for probiotics in psoriasis and some early positive findings, the overall quality of evidence is low. There are no large-scale, high-quality randomized controlled trials to firmly establish efficacy, optimal strains, or dosing regimens. As a result, probiotics are sometimes used as an adjunctive approach in managing psoriasis, but they should not replace established therapies. Clinicians and patients should interpret current findings with caution until more robust evidence is available.

More about Probiotic (unspecified)
More about Psoriasis

Other ingredients used for Psoriasis

Other health conditions supported by Probiotic (unspecified)

Products containing Probiotic (unspecified)